Core Viewpoint - Meili Tianyuan Medical Health (2373.HK) has announced a significant acquisition that will enhance its market presence and revenue potential in the Greater Bay Area [1] Group 1: Acquisition Details - Meili Tianyuan's subsidiary, Nairui Medical Devices and Nairui Health Management, has signed a share transfer agreement with Guangzhou Beiminsheng Enterprise Management Co., Ltd. [1] - The total transaction value for the acquisition is RMB 40 million [1] - Upon completion of the transaction, Meili Tianyuan will hold a 90% stake in the target company, making it a non-wholly owned subsidiary of the group [1] Group 2: Business Expansion - The acquisition will add 19 new direct-operated stores to Meili Tianyuan's portfolio, including 2 medical beauty stores and 17 lifestyle beauty stores [1] - This expansion will deepen the company's market penetration in key cities of the Greater Bay Area, significantly enhancing its revenue potential [1]
港股异动丨美丽田园医疗健康涨超4% 收购相关资产预计将新增19家直营门店